Daclizumab Subcutaneous and Hydrochlorothiazide and olmesartan
Determining the interaction of Daclizumab Subcutaneous and Hydrochlorothiazide and olmesartan and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: hydrochlorothiazide / olmesartan
Brand name: Benicar HCT
Synonyms: Olmesartan and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Hydrochlorothiazide and propranolol
- Daclizumab Subcutaneous-Hydrochlorothiazide and quinapril
- Daclizumab Subcutaneous-Hydrochlorothiazide and spironolactone
- Daclizumab Subcutaneous-Hydrochlorothiazide and telmisartan
- Daclizumab Subcutaneous-Hydrochlorothiazide and triamterene
- Daclizumab Subcutaneous-Hydrochlorothiazide and valsartan
- Hydrochlorothiazide and olmesartan-Dacogen
- Hydrochlorothiazide and olmesartan-Dacomitinib
- Hydrochlorothiazide and olmesartan-Dactinomycin
- Hydrochlorothiazide and olmesartan-Dactinomycin Injection
- Hydrochlorothiazide and olmesartan-Dactinomycin Intravenous
- Hydrochlorothiazide and olmesartan-Daklinza